Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News Mycoprotein production - Kynda secures 3 million euro seed With the support of Enjoy Ventures, PHW Group and Clima Now, the start-up is scaling up its sustainable fermentation solution for food and animal feed production.

Marc Nemitz 19.02.2025

News InfectoPharm invests in AudioCure InfectoPharm joins AudioCure Pharma as a new investor. Together with MED-EL and High-Tech Gründerfonds, the development of AC102 is to be further advanced

Marc Nemitz 13.02.2025

News Bürkert Fluid Control Systems invests in Green Elephant Biotech The strategic partnership with the start-up aims to enable resource-saving bioreactors for the pharmaceutical industry.

Marc Nemitz 13.02.2025

News Phaeosynt secures 1.7 million euros seed for market entry With a successful financing round, Phaeosynt is ready for the next phase of growth. The biotech start-up focuses on vegan antibody technology for sustainable diagnostics.

Marc Nemitz 12.02.2025

Reports Germany leads the way in oncology start-ups Germany is one of the European leaders in cancer-related patents and start-ups. However, according to a new study by the EPO, scaling up remains a challenge.

Marc Nemitz 03.02.2025

News SRTD biotech receives seed financing The seed funding makes it possible to further develop a platform for targeted RNA therapies. The goal: better cancer therapies without side effects.

Marc Nemitz 14.11.2024

News BioNTech acquires Biotheus for 800 million euros The acquisition of Biotheus gives BioNTech worldwide rights to BNT327/PM8002 and further advances research into innovative combination cancer therapies.

Marc Nemitz 13.11.2024

News SynOx Therapeutics increases capital to USD 92 million in Series B financing Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor

Marc Nemitz 30.10.2024

News Infinite Roots receives 2.6 million euros in funding Infinite Roots transforms whey waste into valuable resources. The Hamburg-based biotech company aims to use whey as a substrate for mycelium production and create new, environmentally friendly products.

Marc Nemitz 17.10.2024

News Reliant AI launches with seed funding of 11.3 million dollars The startup is launching Reliant Tabular, an AI workbench designed to radically accelerate data processing in the biopharma industry.

Marc Nemitz 20.08.2024

1
2
3
4